Neoadjuvant palbociclib plus either giredestrant or anastrozole in oestrogen receptor-positive, HER2-negative, early breast cancer (coopERA Breast Cancer): an open-label, randomised, controlled, phase 2 study
- coopERA Breast Cancer study group
- University of California at Los Angeles
- Fred Hutchinson Cancer Research Center
- Harvard University
- San Sebastián de los Reyes
- Institute Catala Oncologia
- Hospital Universitario San Cecilio
- University of Granada
- Hospital Virgen de la Arrixaca
- NSHI Road Clinical Hospital of JSC Russian Railways
- Communal Enterprise Kryvyi Rih Oncology Dispensary
- Hospital do Câncer de Pernambuco
- Sarah Cannon Research Institute
- Communal Non-profit Enterprise Odesa Regional Clinical Hospital of Odesa Regional Council
- Hospital Universitario La Paz
- Torrance Memorial Hunt Cancer Center
- Translational Research in Oncology
- F Hoffmann-La Roche
- Roche Products Limited UK
- F. Hoffmann-La Roche AG
- Genentech, Inc
- Friedrich-Alexander University Erlangen-Nürnberg
Research output: Contribution to journal › Article › peer-review
36
Link opens in a new tab
Scopus
citations